Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|March 10, 2018
Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancerMisato Okazaki, Yoshiya Horimoto, Masahiko Tanabe, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy]Kiyoko Asai, Toyoki Fujita, Yuki Nakamura, et al.Cancer Research|April 8, 2014
Phosphatidylinositol 4-phosphate in the Golgi apparatus regulates cell-cell adhesion and invasive cell migration in human breast cancerEmi Tokuda, Toshiki Itoh, Junya Hasegawa, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 8, 2024
Development of cancer therapy-related cardiac dysfunction in anthracycline-treated breast cancer patients: a retrospective studyJunko Kuroda, Masayoshi Oikawa, Emi Tokuda, et al.Journal of Cell Science|September 8, 2019
SH3YL1 cooperates with ESCRT-I in the sorting and degradation of the EGF receptorJunya Hasegawa, Imen Jebri, Hikaru Yamamoto, et al.The Journal of Cell Biology|June 1, 2011
SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositide-binding domainJunya Hasegawa, Emi Tokuda, Takeshi Tenno, et al.Cancer Chemotherapy and Pharmacology|November 16, 2011
Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patientsKatsuya Nakai, Hiroyuki Mitomi, Yimit Alkam, et al.Journal for Immunotherapy of Cancer|October 2, 2020
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumabYutaka Natori, Eisaku Sasaki, Shu Soeda, et al.Breast Cancer (Tokyo, Japan)|April 17, 2020
Decreased ER dependency after acquired resistance to CDK4/6 inhibitorsMasafumi Iida, Daichi Toyosawa, Misato Nakamura, et al.Oncotarget|August 27, 2019
The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancerMasafumi Iida, Misato Nakamura, Emi Tokuda, et al.Pageof 4